The Anti-inflammatory and Anti-angiogenic Role of Mesenchymal Stem Cells in Corneal Wound Healing Following Chemical Injury
Overview
Reproductive Medicine
Affiliations
To investigate the anti-inflammatory and anti-angiogenic effects of mesenchymal stem cells (MSC) in the chemically burned corneas, we mechanically removed the corneal epithelium of rats after 100% alcohol instillation. The rats were then randomized into four groups: fresh media, conditioned media derived from the MSC culture (MSC-CM), MSC applied topically to the damaged corneas for 2 hours immediately after the injury or MSC-CM applied either once or 3 times per day for 3 consecutive days. Corneal surface was evaluated every week. After 3 weeks, the corneas were stained with the hematoxylin-eosin, and the expression of interleukin (IL)-2, interferon (IFN)-gamma, IL-6, IL-10, transforming growth factor (TGF)-beta1, thrombospondin-1 (TSP-1), matrix metalloproteinase-2 (MMP-2), and vascular endothelial growth factor (VEGF) were analyzed. CD4+ cells were assessed in the corneas. We found that both MSC and three-time applied MSC-CM (1) reduced corneal inflammation and neovascularization, (2) decreased IL-2 and IFN-gamma, although increased IL-10 and TGF-beta1 as well as IL-6, (3) reduced the infiltration of CD4+ cells, and (4) upregulated the expression of TSP-1, although downregulated that of MMP-2. Interestingly, whereas three-time application of MSC-CM was partially effective, transplantation of MSC achieved a better outcome in suppressing corneal inflammation. The results of this study suggest that the anti-inflammatory and anti-angiogenic action of MSC in the chemically burned corneas might be mediated in part through paracrine pathways involving soluble factors such as IL-10, TGF-beta1, IL-6 and TSP-1.
Han X, Ju L, Sands M, Zhao Y, Irudayaraj J ACS Pharmacol Transl Sci. 2025; 8(2):602-612.
PMID: 39974628 PMC: 11833733. DOI: 10.1021/acsptsci.4c00724.
Biomedical Application of MSCs in Corneal Regeneration and Repair.
De Miguel M, Cadenas-Martin M, Stokking M, Martin-Gonzalez A Int J Mol Sci. 2025; 26(2).
PMID: 39859409 PMC: 11766311. DOI: 10.3390/ijms26020695.
Hermankova B, Javorkova E, Palacka K, Holan V Cell Transplant. 2025; 34:9636897241312798.
PMID: 39856809 PMC: 11760125. DOI: 10.1177/09636897241312798.
Advances in the Diagnosis and Management of Limbal Stem Cell Deficiency.
Kittipibul T, Dalin C, Masoudi A, Zheng J, Deng S Cornea. 2024; 44(4):405-411.
PMID: 39729420 PMC: 11875906. DOI: 10.1097/ICO.0000000000003775.
Kengkla P, Panyasing Y, Thayananuphat A, Tuntivanich N Animals (Basel). 2024; 14(22).
PMID: 39595323 PMC: 11591453. DOI: 10.3390/ani14223270.